Toxic effects of 5-Fluorouracil on sperm count in wistar rats

Urban J A D'Souza1

  • 1Department of Physiology, School of Medical Sciences, Universiti Sains Malaysia, Health Campus, 16150 Kubang Kerian, Kelantan, Malaysia.

Insights

The chemotherapy drug 5-fluorouracil significantly reduced sperm count in rats. This effect was dose- and time-dependent, impacting male fertility and reproductive health.

Area of Science:

  • Reproductive toxicology
  • Pharmacology
  • Cancer therapy

Background:

  • 5-fluorouracil (5-FU) is a common antimetabolite chemotherapy agent.
  • While 5-FU's testicular toxicity is known, its specific impact on spermatogenesis remains understudied.
  • Understanding 5-FU's effects on sperm production is crucial for managing cancer patient fertility.

Purpose of the Study:

  • To investigate the impact of 5-fluorouracil on epididymal sperm count in a rat model.
  • To determine if 5-FU affects spermatogenesis in a dose- and time-dependent manner.

Main Methods:

  • Male Wistar rats received daily intraperitoneal injections of 5-FU (10, 20, or 30 mg/kg) or distilled water for five consecutive days.
  • Epididymal sperm counts were assessed at 14, 35, 42, and 70 days post-injection.
  • Sperm samples were collected, stained with eosin Y, and quantified using standard procedures.
  • Statistical analysis was performed using the Mann Whitney U test.

Main Results:

  • 5-fluorouracil administration led to a significant reduction in epididymal sperm count.
  • The decrease in sperm count was observed to be both dose-dependent and time-dependent.
  • Higher doses and longer durations post-injection correlated with lower sperm counts.

Conclusions:

  • 5-fluorouracil adversely affects spermatogenesis, leading to reduced sperm counts.
  • The findings highlight a significant risk of impaired male fertility associated with 5-FU treatment.
  • Further research into protective strategies against 5-FU-induced reproductive toxicity is warranted.

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Spermatogenesis01:41

Spermatogenesis

Spermatogenesis is the process by which haploid sperm cells are produced in the male testes. It starts with stem cells located close to the outer rim of seminiferous tubules. These spermatogonial stem cells divide asymmetrically to give rise to additional stem cells (meaning that these structures “self-renew”), as well as sperm progenitors, called spermatocytes. Importantly, this method of asymmetric mitotic division maintains a population of spermatogonial stem cells in the male reproductive...